Cargando…
ERK1 indicates good prognosis and inhibits breast cancer progression by suppressing YAP1 signaling
The mitogen-activated protein kinase/extracellular signal-regulated (MAPK/ERK) pathway is a well-characterized signaling pathway during the development of various cancer types. ERK1 and ERK2, the two kinase effectors of MAPK cascade, exhibit high similarity. However, it is still unknown whether thes...
Autores principales: | Yu, Shiyi, Zhang, Meng, Huang, Ling, Ma, Zhifang, Gong, Xue, Liu, Weiguang, Zhang, Jun, Chen, Liming, Yu, Zhenghong, Zhao, Weiyong, Liu, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6949071/ https://www.ncbi.nlm.nih.gov/pubmed/31848326 http://dx.doi.org/10.18632/aging.102572 |
Ejemplares similares
-
Adhesion glycoprotein CD44 functions as an upstream regulator of a network connecting ERK, AKT and Hippo-YAP pathways in cancer progression
por: Yu, Shiyi, et al.
Publicado: (2014) -
CD44 promotes hepatocellular carcinoma progression via upregulation of YAP
por: Zhang, Jun, et al.
Publicado: (2021) -
Protein tyrosine phosphatase PTPL1 suppresses lung cancer through Src/ERK/YAP1 signaling
por: Wang, Jing, et al.
Publicado: (2022) -
CIAPIN1 Targeted NHE1 and ERK1/2 to Suppress NSCLC Cells' Metastasis and Predicted Good Prognosis in NSCLC Patients Receiving Pulmonectomy
por: Wang, Jian, et al.
Publicado: (2019) -
Protein Kinase D3 promotes the cell proliferation by activating the ERK1/c‐MYC axis in breast cancer
por: Liu, Yan, et al.
Publicado: (2020)